Valuation: Compugen Ltd.

Market Cap 219M 195M 182M 165M 312M 21.07B 314M 2.2B 855M 10.76B 821M 804M 34.57B P/E 2026 *
-8.25x
P/E 2027 * -8.37x
Enterprise Value 219M 195M 182M 165M 312M 21.07B 314M 2.2B 855M 10.76B 821M 804M 34.57B EV / Sales 2026 *
23.7x
EV / Sales 2027 * 28.2x
Free-Float
99.82%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Compugen Ltd.

1 week-0.86%
Current month-2.94%
1 month-10.81%
3 months+1.32%
6 months+2.21%
Current year+50.98%
1 week 2.25
Extreme 2.25
2.44
1 month 2.25
Extreme 2.25
2.62
Current year 1.51
Extreme 1.51
3.24
1 year 1.43
Extreme 1.43
3.24
3 years 0.53
Extreme 0.53
3.24
5 years 0.51
Extreme 0.51
7.48
10 years 0.51
Extreme 0.51
19.9
Manager TitleAgeSince
Chief Executive Officer - 22/09/2025
Director of Finance/CFO 42 14/08/2024
Chief Operating Officer 49 31/12/2023
Director TitleAgeSince
Chairman 59 22/09/2025
Director/Board Member 59 10/06/2018
Director/Board Member 70 10/06/2018
Date Insider Type Main position Quantity % Market Cap. Importance
29/07/26 Free

Chief Operating Officer

70,000 0.0740%
29/07/26 Free

Chairman

100,000 0.1058%
29/07/26 Free

Chief Financial Officer

45,500 0.0481%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.86%+41.72%+159.84% 219M
+4.16%+3.42%+49.37%+94.17% 74.31B
+1.87%-2.48%+21.71%+76.95% 56.95B
+2.59%+1.20%+6.07%+37.76% 48.3B
+0.50%+2.94%+344.62%+722.17% 44.51B
+3.05%-1.80%+28.78%+34.51% 43.8B
+1.00%-1.46%+5.17%+111.90% 41.12B
-0.54%+2.41%+9.31%+58.85% 31.07B
+4.51%+8.22%+37.86%+32.49% 28.97B
+0.76%-1.45%-7.44%-11.12% 24.53B
Average +1.79%-0.43%+53.72%+131.75% 39.38B
Weighted average by Cap. +2.21%-0.46%+58.98%+137.12%

Financials

2026 *2027 *
Net sales 9.24M 8.24M 7.68M 6.99M 13.16M 890M 13.26M 92.78M 36.1M 454M 34.68M 33.93M 1.46B 7.75M 6.91M 6.44M 5.86M 11.04M 746M 11.12M 77.83M 30.28M 381M 29.09M 28.47M 1.22B
Net income -26.46M -23.61M -22M -20.02M -37.7M -2.55B -37.97M -266M -103M -1.3B -99.35M -97.21M -4.18B -26.95M -24.04M -22.4M -20.38M -38.39M -2.6B -38.67M -271M -105M -1.32B -101M -98.99M -4.26B
Net Debt - -
Logo Compugen Ltd.
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.
Employees
75
Date Price Change Volume
05/10/26 US$2.310 0.00% 198,865
02/10/26 US$2.310 -1.28% 113,986
01/10/26 US$2.340 -1.68% 173,346
30/09/26 US$2.380 +1.28% 118,236
29/09/26 US$2.350 +0.86% 117,182
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.310USD
Average target price
4.600USD
Spread / Average Target
+99.13%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CGEN Stock